What are the coverage criteriaBMI, health conditions, step therapy
The pioneering work in the GLP-1 field was carried out in parallel in the United States and Denmark, the historical centers (along with Canada) of insulin pharmacology, and eventually spawned blockbuster drugs like Victoza, Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound that have dominated recent public conversations in science, medicine, and popular culture [1, 2]
Target: 64-80 ounces daily minimum (thats 8-10 cups)
Complimenting the long overdue shift in philosophy to conceptualize metabolic dysfunction as a cabal of multisystem comorbidities driven by diet-induced obesity and insulin resistance of which MAFLD is but one manifestation, there has been growing interest in nurturing and/or repurposing therapies that may have multipronged benefits upon the herein-labeled cardiovascular-kidney-liver-metabolic (CKLM) axis